# Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

> **NCT06235099** · PHASE3 · COMPLETED · sponsor: **Curium US LLC** · enrollment: 235 (actual)

## Conditions studied

- Prostate Cancer
- Prostate Adenocarcinoma
- Biochemical Recurrence of Malignant Neoplasm of Prostate

## Interventions

- **DRUG:** Copper Cu 64 PSMA I&T

## Key facts

- **NCT ID:** NCT06235099
- **Lead sponsor:** Curium US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2025-02-18
- **Final completion:** 2025-02-18
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06235099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06235099, "Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06235099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*